Invention Grant
![Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitors](/docs/US/2021-10-05/US11136323B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitors
-
Application No.: US16466621Application Date: 2017-12-07
-
Publication No.: US11136323B2Publication Date: 2021-10-05
- Inventor: Jing Li , Haibo Zhao , Zhiwei Wang
- Applicant: BEIGENE, LTD.
- Applicant Address: KY Grand Cayman
- Assignee: BEIGENE, LTD.
- Current Assignee: BEIGENE, LTD.
- Current Assignee Address: KY Grand Cayman
- Agency: Cooley LLP
- Priority: WOPCT/CN2016/108897 20161207
- International Application: PCT/CN2017/114970 WO 20171207
- International Announcement: WO2018/103688 WO 20180614
- Main IPC: C07D487/04
- IPC: C07D487/04
![Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitors](/abs-image/US/2021/10/05/US11136323B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed is a compound of Formula (I), or a stereoisomer thereof or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating PI3Kδ related disorders or diseases by using the compound disclosed herein.
Information query
